Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hypoxia × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Motor Activity 189 Breast Neoplasms 107 Neoplasms 78 Prostatic Neoplasms 31 Fatigue 26 Obesity 21 Colorectal Neoplasms 18 Lung Neoplasms 14 Polycystic Ovary Syndrome 13 Ovarian Neoplasms 12 Colonic Neoplasms 12 Head and Neck Neoplasms 10 Rectal Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Lymphoma 9 Multiple Myeloma 8 Lymphedema 8 Hematologic Neoplasms 8 Brain Neoplasms 8 Weight Loss 7 Pancreatic Neoplasms 7 Insulin Resistance 7 Cardiotoxicity 7 Carcinoma, Non-Small-Cell Lung 7 Leukemia 6 Cognitive Dysfunction 6 Sarcopenia 5 Peripheral Nervous System Diseases 5 Overweight 5 Lymphoma, Follicular 5

Interventions

TH 302 4 3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 4 pimonidazole 3 Propofol 3 Injections 3 fluoroazomycin arabinoside 2 Radiotherapy 2 pomalidomide 1 fluoromisonidazole 1 fludarabine 1 Tirapazamine 1 Temozolomide 1 Sodium Chloride 1 Sevoflurane 1 Saline Solution 1 Oxygen 1 Nitroglycerin 1 Nimorazole 1 Magnetic Resonance Spectroscopy 1 Ketamine 1 Ipilimumab 1 Hydroxychloroquine 1 Furosemide 1 Ferrosoferric Oxide 1 Exercise 1 Ethiodized Oil 1 Diagnostic Imaging 1 Dexmedetomidine 1 Dexamethasone 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03365076 2023-01-09

EXIPOX

University Hospital of North Norway

Phase NA Terminated

Hypoxia, Motor Activity, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡